Medicare Enrolled
Dr. Noor Merchant, M.D.
Internal Medicine · Sebastian, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Merchant from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Merchant? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Merchant
Dr. Noor Merchant is an internal medicine in Sebastian, FL, with 20 years in practice. Based on federal Medicare data, Dr. Merchant performed 226,310 Medicare services across 6,482 unique beneficiaries.
Between the years covered by Open Payments, Dr. Merchant received a total of $26,281 from 95 pharmaceutical and/or device companies across 1426 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Merchant is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 0% volume in FL$ $26,281 industry payments
Medicare Practice Summary
Medicare Utilization ↗226,310
Medicare services
Top 0% in FL for internal medicine
6,482
Unique beneficiaries
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~11,316 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 72,930 | $0 | $4 |
| Pembrolizumab injection (Keytruda) | 24,400 | $43 | $137 |
| Anti-nausea injection (aprepitant) | 15,470 | $1 | $5 |
| Nivolumab injection (Opdivo) | 13,600 | $24 | $72 |
| Daratumumab injection (Darzalex) | 12,240 | $38 | $110 |
| Oxaliplatin chemotherapy injection | 10,568 | $0 | $12 |
| Epoetin alfa injection (Procrit) for anemia | 10,560 | $6 | $23 |
| Iron sucrose injection (Venofer) | 9,500 | $0 | $5 |
| Denosumab injection (Prolia/Xgeva) | 8,460 | $18 | $51 |
| Inclisiran injection (Leqvio) for cholesterol | 7,100 | $9 | $49 |
| Immune globulin infusion (Gammagard) | 6,178 | $36 | $108 |
| Paclitaxel chemotherapy injection | 5,388 | $0 | $2 |
| Dexamethasone injection (steroid) | 3,136 | $0 | $3 |
| Complete blood count (CBC) with differential | 2,637 | $8 | $29 |
| Iron infusion (Monoferric) | 2,500 | $16 | $57 |
| Blood draw (venipuncture) | 2,281 | $8 | $9 |
| Injection, bortezomib, 0.1 mg | 1,897 | $4 | $113 |
| Injection, durvalumab, 10 mg | 1,796 | $62 | $191 |
| Epoetin alfa injection (Retacrit) for anemia | 1,650 | $6 | $22 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,630 | $1 | $28 |
| Anti-nausea injection (ondansetron/Zofran) | 1,176 | $0 | $9 |
| Contrast dye for imaging (iodine-based) | 1,140 | $0 | $1 |
| Drug injection, under skin or into muscle | 914 | $11 | $69 |
| Injection, leucovorin calcium, per 50 mg | 875 | $3 | $12 |
| Office visit, established patient (20-29 min) | 873 | $67 | $239 |
| Office visit, established patient (30-39 min) | 784 | $98 | $339 |
| Injection of additional new drug or substance into vein | 670 | $12 | $61 |
| Administration of chemotherapy into vein, 1 hour or less | 599 | $103 | $378 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 595 | $3 | $205 |
| Injection, fluorouracil, 500 mg | 512 | $2 | $7 |
| Red blood count, automated test | 487 | $4 | $10 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 343 | $50 | $189 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 313 | $1 | $6 |
| Injection, diphenhydramine hcl, up to 50 mg | 295 | $1 | $3 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 286 | $23 | $84 |
| Administration of chemotherapy into vein, each additional hour | 214 | $23 | $79 |
| Injection, carboplatin, 50 mg | 203 | $2 | $41 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 179 | $16 | $56 |
| Administration of additional new drug or substance into vein, 1 hour or less | 169 | $52 | $178 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 146 | $134 | $562 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 139 | $26 | $89 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 129 | $57 | $206 |
| Injection, zoledronic acid, 1 mg | 122 | $7 | $69 |
| Infusion, normal saline solution , 1000 cc | 117 | $2 | $7 |
| Infusion into a vein for hydration, 31-60 minutes | 90 | $26 | $156 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 86 | $18 | $59 |
| Injection of drug or substance into vein | 85 | $30 | $156 |
| Automated urinalysis | 70 | $2 | $8 |
| Administration of additional new drug or substance into vein using push technique | 66 | $44 | $170 |
| Injection, leuprolide acetate for depot suspension (cipla), 7.5 mg | 63 | $300 | $1,210 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 62 | $4 | $15 |
| Initial hospital admission, high complexity | 57 | $138 | $556 |
| New patient office visit (30-44 min) | 55 | $90 | $298 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 54 | $128 | $637 |
| Hospital follow-up visit, low complexity | 53 | $39 | $109 |
| Initial hospital admission, moderate complexity | 51 | $102 | $377 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 48 | $1 | $7 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 46 | $16 | $56 |
| Hospital follow-up visit, moderate complexity | 45 | $64 | $197 |
| Drawing of blood for a medical problem | 41 | $69 | $277 |
| New patient office visit (45-59 min) | 31 | $126 | $453 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 30 | $3 | $11 |
| Office visit, established patient (10-19 min) | 26 | $37 | $147 |
| Infusion into a vein for hydration, each additional hour | 25 | $10 | $42 |
| Office visit, established patient, complex (40-54 min) | 13 | $145 | $474 |
| Ct scan of abdomen and pelvis before and after contrast | 12 | $208 | $708 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
36.6% high complexity
59.9% medium
3.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$26,281
Total received (2018-2024)
Avg $3,754/year across 7 years
Top 3% in FL for internal medicine
95
Companies
1,426
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$24,064 (91.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,166 (4.4%)
Other
Charitable contributions, space rental, and other categories
$1,051 (4.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$4,501
2023$3,667
2022$4,134
2021$4,487
2020$2,988
2019$3,327
2018$3,177
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$2,909
PFIZER INC.
$1,918
E.R. Squibb & Sons, L.L.C.
$1,729
Janssen Biotech, Inc.
$1,470
AstraZeneca Pharmaceuticals LP
$1,433
Celgene Corporation
$1,119
Amgen Inc.
$950
GlaxoSmithKline, LLC.
$790
Merck Sharp & Dohme Corporation
$772
Astellas Pharma US Inc
$761
Genentech USA, Inc.
$733
Merck Sharp & Dohme LLC
$697
Lilly USA, LLC
$659
Pharmacyclics LLC, An AbbVie Company
$654
GENZYME CORPORATION
$633
Incyte Corporation
$610
Seagen Inc.
$595
Daiichi Sankyo Inc.
$472
Takeda Pharmaceuticals U.S.A., Inc.
$431
Bayer HealthCare Pharmaceuticals Inc.
$377
Ipsen Biopharmaceuticals, Inc
$351
Gilead Sciences, Inc.
$342
Regeneron Healthcare Solutions, Inc.
$312
ABBVIE INC.
$309
JAZZ PHARMACEUTICALS INC.
$293
BeiGene USA, Inc.
$258
TESARO, Inc.
$252
Eisai Inc.
$235
Boehringer Ingelheim Pharmaceuticals, Inc.
$206
AVEO Pharmaceuticals, Inc.
$192
ARRAY BIOPHARMA INC
$192
EISAI INC.
$182
Karyopharm Therapeutics Inc.
$168
Puma Biotechnology, Inc.
$163
Kite Pharma, Inc.
$156
SOBI, INC
$150
Seattle Genetics, Inc.
$148
Taiho Oncology, Inc.
$140
Bayer Healthcare Pharmaceuticals Inc.
$129
Pharmacosmos Therapeutics Inc.
$127
AbbVie Inc.
$122
Clovis Oncology, Inc.
$120
EMD Serono, Inc.
$107
Dova Pharmaceuticals
$101
Pharmacyclics LLC, an AbbVie Company
$97
Aveo Pharmaceuticals, Inc.
$81
AMAG Pharmaceuticals, Inc.
$73
PUMA BIOTECHNOLOGY, INC.
$71
ADC Therapeutics America, Inc.
$70
Dendreon Pharmaceuticals LLC
$66
Stemline Therapeutics Inc.
$64
Rigel Pharmaceuticals, Inc.
$60
EUSA Pharma (US) LLC
$58
Myriad Genetic Laboratories, Inc.
$56
Agios Pharmaceuticals, Inc.
$55
Myovant Sciences Inc.
$54
Helsinn Therapeutics (U.S.), Inc.
$52
SERVIER PHARMACEUTICALS LLC
$47
Biocon Biologics Inc
$46
AbbVie, Inc.
$45
Alexion Pharmaceuticals, Inc.
$44
Sobi, Inc
$40
Alnylam Pharmaceuticals Inc.
$39
TerSera Therapeutics LLC
$35
Lexicon Pharmaceuticals, Inc.
$34
Janssen Pharmaceuticals, Inc
$34
Global Blood Therapeutics, Inc.
$31
Sysmex Inostics Inc
$29
MorphoSys, US Inc.
$28
Blueprint Medicines Corporation
$26
Adaptive Biotechnologies Corporation
$26
Legend Biotech USA Inc.
$26
Heron Therapeutics, Inc.
$25
PharmaEssentia USA Corporation
$24
Secura Bio, Inc.
$23
Exelixis Inc.
$23
Ferring Pharmaceuticals Inc.
$22
Novocure Inc.
$22
Geron Corporation
$22
Mirati Therapeutics, Inc.
$21
TAIHO ONCOLOGY, INC.
$21
Shire North American Group Inc
$20
Kyowa Kirin, Inc.
$19
Advanced Accelerator Applications
$19
Partner Therapeutics, Inc.
$18
Sirtex Medical Inc
$17
Octapharma USA, Inc.
$17
Medtronic USA, Inc.
$17
CSL Behring
$17
Array BioPharma Inc.
$16
Sun Pharmaceutical Industries Inc.
$15
SUN PHARMACEUTICAL INDUSTRIES INC.
$14
Deciphera Pharmaceuticals Inc.
$14
Tactile Systems Technology Inc
$13
Boston Scientific Corporation
$11
Top 3 companies account for 24.9% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · ADVATE · AFINITOR · AKYNZEO · ALIMTA · ALUNBRIG · AYVAKIT · Abraxane · Afstyla · Alecensa · Aliqopa · Avastin · BAVENCIO · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Blincyto · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · CERDELGA · CHANTIX · CINVANTI · COSELA · CYRAMZA · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIQUIS · ELITEK · ELREXFIO · EMEND · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · EXKIVITY · Enhertu · FARYDAK · FASENRA · FASLODEX · FERAHEME · FIRMAGON · FLEXITOUCH · FOTIVDA · FRUZAQLA · Farydak · Fulphila · GAMMAGARD · GAZYVA · GILOTRIF · GIVLAARI · Halaven · Herceptin · IBRANCE · IDHIFA · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LEUKINE · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LORBRENA · LUMAKRAS · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lutathera · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · MYRISK · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · ONPATTRO · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OSTEOCOOL RF ABLATION · OXBRYTA · Ogivri · Oncology · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POLARIS · POLIVY · POTELIGEO · PROMACTA · PROVENGE · PYRUKYND · Padcev · Perjeta · Pomalyst · Prolia · QINLOCK · QUZYTTIR · REBLOZYL · RETEVMO · RYBREVANT · RYTELO · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · SUTENT · Somatuline Depot · Stivarga · Sylvant · TAGRISSO · TALVEY · TASIGNA · TECENTRIQ · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tazverik · Tecentriq · Tibsovo · Trodelvy · ULTOMIRIS · VARUBI · VENCLEXTA · VERZENIO · VESICARE · VONJO · VONVENDI · VOTRIENT · Venclexta · Vitrakvi · Vyloy · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZIIHERA · ZYTIGA · Zoladex · clonoSEQ · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (92%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 3% for internal medicine in FL.
Equivalent to $12 per 100 Medicare services performed
Geographic Context
Internal Medicines within 10 mi
232
Per 100K population
141.6
County median income
$71,049
Nearest hospital
ORLANDO HEALTH SEBASTIAN RIVER HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Merchant is a mixed practice specialist, with above-average Medicare volume (top 0% in FL), and high industry engagement (low-engagement, top 3%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Merchant experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Merchant performed 72,930 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Merchant receive payments from pharmaceutical companies?
Yes. Dr. Merchant received a total of $26,281 from 95 companies across 1,426 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Merchant's costs compare to other internal medicines in Sebastian?
Dr. Merchant's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Merchant) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicines in Sebastian
Browse internal medicines in Sebastian ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicines in FL
Internal Medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicines in FL
Which FL internal medicines receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC..
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology